154 related articles for article (PubMed ID: 37303494)
81. An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.
Liu J; Wang P; Zhang P; Zhang X; Du H; Liu Q; Huang B; Qian C; Zhang S; Zhu W; Yang X; Xiao Y; Liu Z; Luo D
J Appl Genet; 2019 Nov; 60(3-4):335-346. PubMed ID: 31372832
[TBL] [Abstract][Full Text] [Related]
82. Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line.
Najjary S; Mohammadzadeh R; Mansoori B; Vahidian F; Mohammadi A; Doustvandi MA; Khaze V; Hajiasgharzadeh K; Baradaran B
Med Oncol; 2021 Oct; 38(12):142. PubMed ID: 34655330
[TBL] [Abstract][Full Text] [Related]
83. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
84. Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.
Garcia AI; Buisson M; Damiola F; Tessereau C; Barjhoux L; Verny-Pierre C; Sornin V; Dondon MG; Eon-Marchais S; ; Caron O; Gautier-Villars M; Coupier I; Buecher B; Vennin P; Belotti M; Lortholary A; Gesta P; Dugast C; Noguès C; Fricker JP; Faivre L; Stoppa-Lyonnet D; Andrieu N; Sinilnikova OM; Mazoyer S
Eur J Hum Genet; 2016 Aug; 24(9):1324-9. PubMed ID: 26785832
[TBL] [Abstract][Full Text] [Related]
85. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
[TBL] [Abstract][Full Text] [Related]
86. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
87. MicroRNA-21 Expression in Primary Breast Cancer Tissue Among Egyptian Female Patients and its Correlation with Chromosome 17 Aneusomy.
Abdel-Hamid NR; Mohammed EA; Abbas AH; Badr FM
Mol Diagn Ther; 2015 Dec; 19(6):365-73. PubMed ID: 26342497
[TBL] [Abstract][Full Text] [Related]
88. Expression and polymorphism of micro-RNA according to body mass index and breast cancer presentation in Tunisian patients.
Belaiba F; Medimegh I; Ammar M; Jemni F; Mezlini A; Romdhane KB; Cherni L; Benammar Elgaaïed A
J Leukoc Biol; 2019 Feb; 105(2):317-327. PubMed ID: 30303554
[TBL] [Abstract][Full Text] [Related]
89. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.
Bandi N; Vassella E
Mol Cancer; 2011 May; 10():55. PubMed ID: 21575235
[TBL] [Abstract][Full Text] [Related]
90. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
[TBL] [Abstract][Full Text] [Related]
91. MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
Zhang Y; Schiff D; Park D; Abounader R
PLoS One; 2014; 9(3):e91546. PubMed ID: 24621885
[TBL] [Abstract][Full Text] [Related]
92. Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer.
Han TY; Hou LS; Li JX; Huan ML; Zhou SY; Zhang BL
Int J Pharm; 2023 Mar; 635():122755. PubMed ID: 36801480
[TBL] [Abstract][Full Text] [Related]
93. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
94. Gamma radiation assisted green synthesis of hesperidin-reduced graphene oxide nanocomposite targeted JNK/SMAD4/MMP2 signaling pathway.
Kodous AS; Taha EO; El-Maghraby DF; Hassana AA; Atta MM
Sci Rep; 2024 May; 14(1):11535. PubMed ID: 38773159
[TBL] [Abstract][Full Text] [Related]
95. Hesperidin - loaded PVA/alginate hydrogel: targeting NFκB/iNOS/COX-2/TNF-α inflammatory signaling pathway.
Kodous AS; Abdel-Maksoud MA; El-Tayeb MA; Al-Sherif DA; Mohamed SSA; Ghobashy MM; Emad AM; Abd El-Halim SM; Hagras SAA; Mani S; Rao AKDM; Hussein AM; Saada HN
Front Immunol; 2024; 15():1347420. PubMed ID: 38686374
[TBL] [Abstract][Full Text] [Related]
96. Exploring research progress in studying serum exosomal miRNA-21 as a molecular diagnostic marker for breast cancer.
Li H; Tie XJ
Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38602645
[TBL] [Abstract][Full Text] [Related]
97. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.
Tariq M; Richard V; Kerin MJ
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002007
[TBL] [Abstract][Full Text] [Related]
98. The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients.
Shaaban NZ; Ibrahim NK; Saada HN; El-Rashidy FH; Shaaban HM; Elbakary NM; Kodous AS
Oncol Res; 2022; 30(6):269-276. PubMed ID: 37303494
[TBL] [Abstract][Full Text] [Related]
99. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
100. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS
PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
